lung cancer

We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
San Francisco Gate, CA
lung cancer
cancer
Merck
Roche
Bristol-Myers Squibb
AACR
non-small cell lung cancer
Flag link:
Qiagen launches liquid biopsy tests for lung, prostate cancer
Qiagen launches liquid biopsy tests for lung, prostate cancer
Drug Delivery Business News
Qiagen
liquid biopsy
lung cancer
prostate cancer
diagnostics
AACR
Flag link:
Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say
Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say
Biopharma Dive
Hanmi Pharm
Korea
lung cancer
Olita
AstraZeneca
Tagrisso
Flag link:
With New Data, Drug Combos, Lung Cancer Experts Scramble to Keep Pace
With New Data, Drug Combos, Lung Cancer Experts Scramble to Keep Pace
Xconomy
lung cancer
immuno-oncology
Flag link:
Visiongate Announces Next Step in Commercialization of Cancer Detection Platform
Visiongate Announces Next Step in Commercialization of Cancer Detection Platform
CP Wire
VisionGate
cancer
diagnostics
Cell-CT
LuCED Lung Test
lung cancer
Flag link:
Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib
Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib
Endpoints
Pfizer
priority review
FDA
lung cancer
dacomitinib
Flag link:
Roche's Avastin could get a boost with Tecentriq's second lung cancer win this week
Roche's Avastin could get a boost with Tecentriq's second lung cancer win this week
Fierce Pharma
Roche
Avastin
Tecentriq
lung cancer
Flag link:
Roche's Tecentriq cocktail notches another lung cancer success
Roche's Tecentriq cocktail notches another lung cancer success
Yahoo/Reuters
Roche
Tecentriq
lung cancer
clinical trials
Flag link:
Is AbbVie 'Unraveling' In Solid Tumor Market After Drug Misstep?
Is AbbVie 'Unraveling' In Solid Tumor Market After Drug Misstep?
Investors Business Daily
AbbVie
solid tumors
Rova-T
lung cancer
Flag link:
Auris Health’s Surgical Robot Gets FDA Green Light for Lung Cancer
Auris Health’s Surgical Robot Gets FDA Green Light for Lung Cancer
Xconomy
Auris Health
devices
robotic surgery
FDA
lung cancer
Monarch robots
Flag link:
Is It Game Over for AbbVie's Promising Cancer Drug?
Is It Game Over for AbbVie's Promising Cancer Drug?
Motley Fool
Rova-T
AbbVie
lung cancer
Flag link:
AbbVie says not seeking accelerated approval for lung cancer drug
AbbVie says not seeking accelerated approval for lung cancer drug
Yahoo/Reuters
AbbVie
drug approvals
accelerated approvals
lung cancer
Rova-T
Flag link:
FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market
Endpoints
FDA
AstraZeneca
Imfinzi
lung cancer
Bavencio
Pfizer
Merck KGaA
Flag link:
Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial
Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial
Yahoo/Reuters
Merck KGaA
Pfizer
lung cancer
Bavencio
clinical trials
Flag link:
Genprex Launch IPO For Trials Of New Gene Therapy Lung Cancer Treatment
Genprex Launch IPO For Trials Of New Gene Therapy Lung Cancer Treatment
Forbes
Genprex
IPOs
gene therapy
lung cancer
Flag link:
Merck's Keytruda extends lung cancer survival in combination trial
Merck's Keytruda extends lung cancer survival in combination trial
Yahoo/Reuters
Merck
Keytruda
lung cancer
clinical trials
Flag link:
Roche's latest Tecentriq results shed little light on the lung cancer market race: analyst
Roche's latest Tecentriq results shed little light on the lung cancer market race: analyst
Fierce Pharma
Roche
Tecentriq
lung cancer
Flag link:
Roche's Tecentriq combo cuts risk of lung cancer progression
Roche's Tecentriq combo cuts risk of lung cancer progression
BioPharma Dive
Roche
Tecentriq
lung cancer
Flag link:
Bristol-Myers set to get a boost in China as Opdivo aces PhIII lung cancer study early
Bristol-Myers set to get a boost in China as Opdivo aces PhIII lung cancer study early
Endpoints
Bristol-Myers Squibb
Opdivo
China
Docetaxel
lung cancer
Flag link:
Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer
Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer
Xconomy
Roche
lung cancer
Genentech
Tecentriq
Flag link:

Pages